MicroVention is a medical technology company based in the United States that specializes in the development and manufacturing of neurovascular medical devices. Founded in 1997, the company's headquarters is located in Tustin, California. The core products of MicroVention are designed to treat patients with various neurovascular conditions such as brain aneurysms, acute ischemic stroke, and carotid artery disease.

The company's innovative solutions include detachable coils, stents, liquid embolics, and flow diversion devices. Operating on a global scale, MicroVention has established a strong presence in key markets around the world. The company has several notable subsidiaries, joint ventures, and partnerships.

In 2006, MicroVention entered into a strategic alliance with Terumo Corporation, a global leader in the medical device industry. This collaboration has allowed MicroVention to leverage Terumo's extensive sales network and expand its reach in international markets. Additionally, MicroVention has subsidiary offices in France and the United Kingdom, further strengthening its global presence.

MicroVention has achieved a strong market position within the neurovascular medical device industry. The company's expertise in developing and manufacturing cutting-edge products has helped establish it as a leading player in the market. With a focus on innovation and clinical excellence, MicroVention's products are highly regarded by healthcare professionals worldwide.

In terms of sales performance, MicroVention has experienced significant growth over the years. The company's success can be attributed to its commitment to research and development, as well as its ability to address the evolving needs of neurovascular patients. MicroVention continues to invest in product development and strategic partnerships to enhance its market position and expand its product lineup.

The company has made significant advancements in the development of novel techniques and technologies, including the introduction of its Pipeline™ Flex Embolization Device, which has revolutionized the treatment of complex brain aneurysms. As of the latest updates, MicroVention remains at the forefront of the industry, continuing to innovate and improve patient outcomes through its neurovascular medical devices. With its strong market presence and commitment to advancing medical technology, MicroVention is poised for continued growth and success